The uses of Treanda (Bendamustine Hydrochloride Injection) are.

Product description


The Bendit drug is an anticancer ("anti-tumor drugs" (also known as "cytotoxic") chemotherapy drug. It's classified by its alkylating drug. The most active alkylating agents occur in the stationary phase in the cycle of cells. It is an derived nitrogen mustard gas that is active against cells that are resting and growing.





Bendet uses:

Bendamustine is used to treat chronic lymphocytic Leukemia (CLL) that is a bone marrow leukocyte tumor. It can also be used to treat B-cells that are indolent non-Hodgkin's Lymphoma.

It does this by degrading DNA, killing cancer cells as well as preventing the spread and growth of cancerous cells.


A few of the side effects of bendamustine are:If you suffer from any of any of the following reactions Please consult your physician:


Aphthous ulcers nausea, vomiting constipation, diarrhea; headache dizziness, fatigue the swelling of the feet or hands and feet, an appetite loss, loss in weight or a mild skin rash

Very severe nausea, vomiting, or diarrhea feeling tired or weak and coughing up green or yellow mucus, wheezing, chest pains, stabbing or shortness of breath. redness, pain, swelling and signs of skin changes or an infection after injection.

Low blood cell count fever chills, flu-like symptoms swelling of gums and aphthous ulcers. Skin sores, rapid heartbeat, white skin, easy bleeding, unusual bruising and dizziness.

A sign of tumor cell rupture is lower back pain blood in urine, minimal or no urination sensations of tingling or numbness in the mouth and mouth muscles, or tightness or weakness and a slow or fast heartbeat faint pulse as well as confusion and fainting.

Signs of dehydration: feeling extremely thirsty or feverish, not being able to flush, sweating excessively or having hot and dry skin.

Constipation, constipation arrhythmias chest flutter, severe thirst, more frequent urination tenderness or tingling muscles, weakness of the muscles or a li sensation.

Skin reactions that are severe, such as swelling of the tongue or face burning eyes, facial discomfort, and then the appearance of red or purple eruptions (especially on the upper or face) and can cause peeling and blisters.

Storage needs:

Keep intact vials in a cool, dry place between 2 between 2 deg and 8 degrees Celsius (36 Deg. F. and 45 deg. F.) and protect them from sunlight.


Safety precautions regarding Bendit Bendamustine injection

Before taking bendamustine, if you are allergic to it then inform your physician or pharmacist. If you are experiencing any other allergic reactions. The product could contain inactive components (such such as mannitol) that could trigger allergic reactions or other issues. Contact your pharmacist for more details.

Before you start using this medicine inform your physician or pharmacist about your medical history, particularly the following: bone marrow or blood illness, kidney problems liver issues Recent or current infections.

Don't immunize without a the approval of your doctor. Avoid contact with anyone who just received live vaccinations (such influenza vaccines inhaled via the nostrils).

This medication can make you feel dizzy or trigger fatigue. Don't drive, operate machines, or engage in any activity that requires alertness and clear sight until you are certain that these activities can be safely performed. Beware of alcohol-related drinks.

This medication can cause dizziness or fatigue. Avoid driving, using machines, or engage in any activity that requires alertness or clear eyes until you are certain that these activities are safe to perform. Avoid drinking alcohol.

It is not advised to take this medication during the pregnancy. It could affect the unborn baby. It is essential to avoid pregnancy while taking this medication as well as within 3 months of treatment. If you are pregnant , suspect you are pregnant or that your partner is pregnant, you should inform your doctor right away.

It isn't clear whether the drug can be absorbed into the breast milk. It is true that breastfeeding taking these medications isn't advised. It is recommended to consult with your physician prior you begin breastfeeding.

The truth about Bendet?

Drug Name: Bendit 100 mg

Dosage: 100 mg

Dosage form: powder lyophilized in an infuser.

Company name: NATCO PHARMA LTD.

Bendit is a bendamustine hydrochloride injection (generic variant of Treanda)


Bendit is part of a group of medications known as alkylating agents. They contain bendamustine. It is used to treat chronic lymphocytic Leukemia (CLL) which is a form of cancer that affects white blood cells. It can also be used to treat non-Hodgkin's Lymphoma. Bendit is a drug that destroys the DNA of cancerous cells, which prevents their growth.


If you'd like to know more details, click here.


 

Comments

Post a Comment

Popular posts from this blog

Treatment for Acute Myeloid Leukemia: IDHIFA (Enasidenib)

Image
  In the world of oncology, breakthroughs in targeted therapies have opened new avenues for the treatment of various types of cancer. One such remarkable advancement is the introduction of IDHIFA (Enasidenib), a medication that has shown great promise in the fight against acute myeloidleukemia (AML) . Understanding IDHIFA and AML:  IDHIFA, known by its generic name Enasidenib, is an oral medication that targets a specific mutation known as isocitrate dehydrogenase 2 (IDH2). Mutations in the IDH2 gene are found in approximately 12-20% of AML patients. These mutations lead to the production of an abnormal form of the IDH2 enzyme, which plays a significant role in the development and progression of AML. Approved Indication: IDHIFA is specifically indicated for the treatment of adult patients with relapsed or refractory AML harboring an IDH2 mutation. It is not intended for use in patients with other types of leukemia or those without the IDH2 mutation. Accessing IDHIFA: Obtaining IDHIFA
Read more

What Patients Should Know about Early Access Programs- AlleviareIndia

Image
  Introduction: In the world of medical research and development, new treatments, drugs, and therapies are constantly being developed to address various health conditions. However, the journey from initial development to final approval by regulatory authorities can be a lengthy process, leaving many patients eagerly awaiting access to potentially life-saving treatments. This is where Early Access Programs (EAPs) come into play. In this article, we will explore what patients should consider when participating in an Early Access Program. Understand the Purpose and Eligibility Criteria: Before considering participation in an Early Access Program, it's important to understand its purpose. EAPs are designed to provide access to investigational treatments for patients who have exhausted all other available options and have a serious or life-threatening condition. Familiarize yourself with the eligibility criteria to determine if you meet the necessary requirements. Discuss with
Read more

Abatacept (Orencia)

Image
Abatacept (Orencia) is often prescribed after failure of an anti-rheumatic agent (DMARD), such as methotrexate. But it can be used as first-line therapy. Ebetasip is used to reduce inflammatory symptoms such as swelling, pain, and stiffness. In the long term, it is expected to prevent joint deformity, therefore helping to maintain range of motion. It is often used in patients with moderate to severe rheumatoid arthritis who have not responded to one or more DMARDs, such as methotrexate, or other biologic drugs. DMARDs are usually tried first. Abatacept may be used alone or in combination with DMARDs, which makes it more potent, but not with other biologic drugs (such as TNF inhibitors). Its use in other diseases is still being studied. Unlike some other biologic drugs, abetacept does not block anti-inflammatory proteins such as TNF-alpha antagonists. Abatacept attaches to the surface of inflammatory cells and blocks communication between these cells. By blocking this communicatio
Read more